Anti-tumour activity of the epipodophyllin derivative VP16-213 (etoposide: NSC-141540) in gestational choriocarcinoma.
D000328:Adult; D001761:Bleomycin / Q000627:therapeutic use; D002822:Choriocarcinoma / Q000097:blood / Q000188:drug therapy*; D006063:Chorionic Gonadotropin / Q000097:blood; D004359:Drug Therapy, Combination; D005047:Etoposide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D011247:Pregnancy; D014594:Uterine Neoplasms / Q000097:blood / Q000188:drug therapy*; D014750:Vincristine / Q000627:therapeutic use
D006063:Chorionic Gonadotropin; D001761:Bleomycin; D014750:Vincristine; D005047:Etoposide; D011034:Podophyllotoxin; D008727:Methotrexate